PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer Dr. Kamal Kant Kohli21 May 2025 8:30 PM ISTThe international PORTEC-4a study offers strong evidence that molecular profiling can safely minimize radiotherapy in women with early-stage...
Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study Dr Riya Dave25 April 2025 8:30 PM ISTResearchers have identified in a new study that high levels of circulating sex hormones have a greater risk of endometrial cancer (EC) in...
GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study Dr Pooja N.6 Feb 2025 8:15 PM ISTEndometrial cancer (EC) ranks as the second most prevalent gynecologic malignancy globally, with approximately 189,000 new cases and 45,000 deaths...
Chronic Stress May Drive Lymph Node Metastasis in Postmenopausal Endometrial Cancer, Study Finds Medha Baranwal26 Jan 2025 9:15 PM ISTSouth Korea: A study published on November 18 in Scientific Reports suggests that brain activity linked to chronic stress may influence the...
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Ruchika Sharma21 Jan 2025 1:30 PM ISTLondon: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy...
Cancer drug: AstraZeneca Pharma India bags CSDCO permission to import Lynparza Ruchika Sharma26 Nov 2024 3:54 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from the Central Drugs...
Predictive Model may Identify Endometrial Hyperplasia and Cancer Risk in Patients with recurrent Uterine Bleed: Study Jacinthlyn Sylvia31 Aug 2024 12:30 AM ISTA recent study made significant steps in predicting the risk of endometrial hyperplasia and endometrial cancer in patients with recurrent abnormal...
Imfinzi, Lynparza combo approved in EU for mismatch repair proficient advanced or recurrent endometrial cancer: AstraZeneca Ruchika Sharma18 Aug 2024 10:00 AM ISTCambridge: AstraZeneca's Imfinzi (durvalumab) and Lynparza (olaparib) have been approved in the European Union (EU) as treatment for certain...
US FDA expands Jemperli plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma2 Aug 2024 10:00 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and...
Transvaginal ultrasound may not be able to detect endometrial cancer in Black women: JAMA Dr. Kamal Kant Kohli11 July 2024 9:30 PM ISTA common algorithm to check for endometrial cancer is not reliable for Black women, according to a new study published today in JAMA Oncology.In Black...
Lynparza, Imfinzi combo recommended for nod in EU by CHMP for endometrial cancer: AstraZeneca Ruchika Sharma3 July 2024 10:00 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU)...
PCOS Linked to Increased Risk of Endometrial Cancer, claims study Dr Riya Dave3 July 2024 7:45 AM ISTResearchers have found that polycystic ovary syndrome (PCOS) is associated with a higher risk of endometrial cancer, with no significant increased...
